Leonard Khiroug, CSO of Neurotar, presents as part of the panel discussion on Strategies for CNS Drug and Device Development. Neurotech Summit comes to Helsinki for the second time in 2013. This established US event for companies active in the field of neuroscience was successfully launched in Europe in 2011. It is a must for […] Read more »
IVM is the only event entirely dedicated to in vivo two-photon (a.k.a. multiphoton) imaging. This year, we have extended the coverage from CNS and immunology to human skin imaging and data analysis. Registration is open until the 26th of May, 2013. Follow this link to the event’s website: http://www.neurotar.com/ivm2013/program-2013/ Welcome! Please contact us if you are interested in […] Read more »
Contact us via partnering software or directly to schedule a meeting.
We will be in the area from February 11th to 14th. We are happy to meet at the seminar. One meeting slot is still open on the 14th. Contact us as soon as possible.
Neurotar’s Katja Karelina (CEO) and Leonard Khiroug (CSO) will be in Stockholm on February 7-8. One meeting slot is still available. Please contact us as soon as possible.
Investors are welcome to schedule meetings with Katja Karelina at the venue or to visit Neurotar during their stay in Helsinki. Contact Katja directly with inquiries.
Neurotar’s sales increased by a factor of 10 in 2012 compared to 2011. Sales revenues come mostly from service provision to companies located outside of Finland. Two of Neurotar’s clients are top ten pharmaceutical companies. Approximately one quarter of revenues comes from cosmetics.
Neurotar presentation in the Biomarker category focuses on the ways in which Neurotar’s services aid biomarker developers and highlights cooperation with the Swedish BioChromix AB in the area of biomarker development for Alzheimer’s.